SYNCARDIA is a non-invasive cardiac regeneration platform designed to repair the heart after a myocardial infarction (heart attack). Using ultrasound-guided lipid nanoparticles and mechanical sensing, it converts scar-forming fibroblasts into electrically integrated heart muscle cells directly within injured tissue. By restoring contractile function while reducing arrhythmia risk, SYNCARDIA aims to move heart attack treatment beyond damage control toward biological repair, with the potential to significantly reduce heart failure and sudden cardiac death.